US Edition
17 Articles
17 Articles
New York, 13 Jun (EFE).- U.S. businesswoman Susan Wojcicki, one of the creators of the broken genetic testing company 23andMe, regained control this Friday by making a bid of 305 million dollars that surpassed the one recently announced by a biotech firm. Wojcicki, who is also the former deputy advisor of 23andMe, entered today into a “final round of bids” in the post-compulsory auction process with the biotechnology company Regeneron, which in …
Anne Wojcicki Wins 23andMe Auction with $305M Bid
In a dramatic turn of events, Anne Wojcicki, co-founder and former CEO of 23andMe, has emerged victorious in a bankruptcy auction for the genetic testing company she once led. Her nonprofit organization, in partnership with a California research institute, secured the winning bid of $305 million, outpacing a competing offer from Regeneron Pharmaceuticals valued at $256 million. This acquisition marks a significant chapter in the tumultuous histo…
Anne Wojcicki Reclaims 23andMe in $305M Deal Through TTAM Institute - USA Herald
In a dramatic turn of events, Anne Wojcicki, co-founder and former CEO of 23andMe, has emerged victorious in a competitive bidding war to regain control of the bankrupt genetic testing company she helped build. Wojcicki’s nonprofit organization, TTAM Research Institute, agreed to acquire nearly all of 23andMe’s assets for $305 million, outbidding biotech giant Regeneron Pharmaceuticals. TTAM Outbids Regeneron in Bankruptcy Sale Regeneron (NASDA…
23andMe's Founder Anne Wojcicki Wins Bid For DNA Testing Firm
Anne Wojcicki, co-founder of 23andMe, has regained control of the bankrupt DNA-testing company after a nonprofit she controls outbid Regeneron Pharmaceuticals with a $305 million offer. The company filed for bankruptcy in March due to declining demand and fallout from a major 2023 data breach. "Th...
Coverage Details
Bias Distribution
- 67% of the sources are Center
To view factuality data please Upgrade to Premium
